Cardiff Oncology
CRDF
CRDF
55 hedge funds and large institutions have $7.86M invested in Cardiff Oncology in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.17% less ownership
Funds ownership: 12.05% → 11.88% (-0.17%)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
Holders
55
Holding in Top 10
–
Calls
$62K
Puts
$48K
Top Buyers
| 1 | +$229K | |
| 2 | +$49.5K | |
| 3 | +$47.1K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$41.1K |
| 5 |
Jane Street
New York
|
+$32.1K |
Top Sellers
| 1 | -$117K | |
| 2 | -$98.2K | |
| 3 | -$91.1K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$84.9K |
| 5 |
Renaissance Technologies
New York
|
-$55.6K |